Call Us Today:
949.200.1600

Atypical Melanocytic Lesions

Home > Diagnosis > Melanoma > Atypical Melanocytic Lesions

Treatment for Atypical Melanocytic Lesions

ABOUT ATYPICAL MELANOCYTIC LESIONS

Atypical melanocytic lesions are also known as atypical melanocytic hyperplasia, atypical mole, or dysplastic mole. The majority of these are benign, however, some have a significant risk of developing into melanoma or actually being a melanoma. This terminology is applied based on either a visual inspection or a biopsy of the lesion.

ATYPICAL MELANOCYTIC LESIONS DIAGNOSED WITH VISUAL INSPECTION

Visual examination of skin can often identify suspicious lesions requiring further evaluation. Five visual characteristics are used to identify the risk of invasive melanoma:

 

A - asymmetry of lesion shape

B - borders that are irregular or blurred

C - color that is variable within a single lesion or different from other moles

D - diameter greater than 6 mm

E - evolution of a mole's appearance - size, color, or shape

 

These are indicators for  a biopsy to rule out melanoma.

ATYPICAL MELANOCYTIC LESION DIAGNOSED ON A BIOPSY

Atypical melanocytic lesions are pigmented moles that have been found to have abnormal cells and are assumed to be at risk for developing into a malignant melanoma. These lesions, once diagnosed as atypical, are typically excised to eliminate the risk of cancer. Although this seems like a prudent approach, scientific evidence for this is frequently lacking. Rationale for excision is based on clinical standards for treating melanoma-in-situ or lentigo maligna.

 

There are three levels of classification of atypical melanocytic lesions:

  • mild atypia in a melanocytic lesion
  • moderate atypia in a melanocytic lesion
  • severe atypia in a melanocytic lesion

 

Most pathologists regard mild and moderate atypia synonymously.

 

Only melanoma-in-situ has adequate evidence to support surgical excision. This particular lesion carries a 5-10% risk of degenerating into malignant melanoma over a 50 year lifetime. This breaks down to a risk of 1-2% per decade. What no one knows is the risk of the atypical melanocytic lesions. Logic would dictate that the risk would be even lower - if present at all.

 

The complete diagnosis of a melanocytic lesion requires a complete excision. These lesions frequently exhibit heterogeneity - variability of abnormality. In other words a lesion with moderate atypia may contain areas of melanoma-in-situ within it. Melanoma-in-situ lesion may contain areas of invasive malignant melanoma. Frequently, this variability is visible with a naked eye and guides clinical decision making.

 

The controversy arises when a biopsy is read as atypical melanocytic lesion with involved margins, and the pathologist recommends additional margin excision. From pathologist's perspective only a complete lesion removal allows for a definitive diagnosis. Complete excision of these atypical melanocytic lesions requires 2 mm margins around the visible lesion for complete clearance. Although most surgeons will not hesitate to excise these lesions completely, scientific evidence to support such approach is lacking. There little evidence that incomplete excision and subsequent lesion recurrence exposes the patient to a greater invasive melanoma risk.  Furthermore, cosmetic considerations may be significant in sensitive areas such as the nose or eyelids. Additional 2 mm margins on all sides of the lesion can drastically change the reconstruction and the outcome. So, each patient and each lesion musts be treated with individual considerations and not necessarily rigid protocols.

 

For in depth discussion of the risks of atypical nevi read this article.

 

Related Articles

melanoma-in-situ-serial-excisions-mohs-excision-platysma-myocutaneous-flap-mapping-biopsy-orange-county-skin-cancer
Management of Recurrent Large Melanoma In Situ
HISTORY 78-year-old man presents with a recurrent melanoma in situ of left cheek in April 2018. Previously, the melanoma in situ was excised in 2001. Patient’s dermatologists performed excision in three stages over a period of 3 weeks to achieve clear margins.  Reconstruction of left cheek was performed with a cheek and neck platysma myocutaneous…
Read More
Skin-Cancer-And-Reconstructive-Surgery-Foundation-melanoma-with-recurrent-MIS1
Melanoma within recurrent MIS
HISTORY   73-year-old woman presents with 1-year history of recurrent pigmented lesion of the right nasal ala  found to be invasive melanoma with 0.5 mm invasion. Patient’s history began 9 years ago in 2009 with excision of a melanoma in situ and skin graft closure. In 2012, pigmentation adjacent to the graft site was found…
Read More
Recurrent-Melanoma-SCARS-Center-Case-2-Skin-Cancer-And-Reconstructive-Surgery-Center-Orange-County4
RECURRENT MELANOMA
  HISTORY 70-year-old woman presents with metastatic melanoma in the right parotid gland region of 1 year duration. Diagnosis was made with a core needle biopsy on 09-08-17. Patient also has small palpable right cervical lymph nodes with SUV 1.6 and 2.0. Patient history of melanoma began in 2001 as a pink macule of the…
Read More
Recurrent-Scalp-Melanoma-SCARS-Center-Case-1-Skin-Cancer-And-Reconstructive-Surgery-Center-Orange-County
RECURRENT SCALP MELANOMA WITH CALVARIAL METASTASES
HISTORY 85-year-old man with history of treated scalp melanoma presented with a 1 month rapidly growing scalp nodule. The original melanoma was treated in 2014 with excision, then re-excision of recurrence, and post-operative radiation in June 2015. The wound developed skin breakdown and osteoradionecrosis and was treated with serial outer table of calvarium debridement. Biopsy…
Read More
Melanoma-Left-Cheek-SCARS-Center-Case-6-Skin-Cancer-And-Reconstructive-Surgery-Center-Orange-County
CHEEK AND EYELID RECONSTRUCTION WITH MULTIPLE PARTIAL ISLAND FLAPS
HISTORY 61-year-old woman presents with several year history of pigmented left cheek and lower lid lesion.  She was initially treated with liquid nitrogen 15 months ago. A biopsy was performed 6-8-17 and revealed melanoma in situ. Excision with close margins performed 6-16-17. Clear margins found on LPMG reading. Second opinion from UCSD was suspicious for…
Read More
Scars Center - Skin Cancer Conference
MULTIPLE ATYPICAL NEVI WITH STRONG FAMILY HISTORY OF CANCER
HISTORY 24-year-old woman presents with multiple atypical nevi.  Almost all lesions had mild atypia, few had focally moderate atypia, and one on her right posterior shoulder had severe atypia and was excised with 5mm margins elsewhere. Family history is significant for melanoma in grandmother and pancreatic cancer in her father. Physical exam showed multiple 2-4…
Read More

STAY UP TO DATE

Receive research updates, inspiring stories, healthy living tips and more.

Something went wrong. Please check your entries and try again.

FOLLOW US

ELEVATING THE STANDARDS OF SKIN CANCER MANAGEMENT.

© 2018 SCARS Management Services. All rights reserved.